Drugmakers to raise prices on over 250 medicines on Jan. 1

NEW YORK >> Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol Myers Squibb’s cancer cell therapies and vaccines from France’s Sanofi at the start of 2025, according to data analyzed by healthcare research firm 3 Axis Advisors.

See the original article at: Honolulu Star-Advertiser